Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000910680-02-000240
Filing Date
2002-02-15
Accepted
2002-02-15 00:00:00
Documents
5
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K - DATED 123101 d10k123101.txt 10-K 276399
3 EXHIBIT 4.8 (EMPLOYEE STOCK OPTION PLAN) exh4_8.txt EX-4 10473
4 EXHIBIT 4.9 (DIRECTORS STOCK OPTION PLAN) exh4_9.txt EX-4 9322
5 EXHIBIT 21.1 (SUBSIDIARIES OF THE REGISTRANT) ex21_1.txt EX-21 522
6 EXHIBIT 23.1 (CONSENT OF INDEPENDENT COUNSEL) exh23_1.txt EX-23 776
  Complete submission text file 0000910680-02-000240.txt   299607
Mailing Address 65 LAFAYETTE RD 3RD FLR NORTH HAMPTON NH 03862
Business Address 65 LAFAYETTE RD 3RD FLR NORTH HAMPTON NH 03862 6039648006
BENTLEY PHARMACEUTICALS INC (Filer) CIK: 0000821616 (see all company filings)

EIN.: 591513162 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10581 | Film No.: 02552283
SIC: 2834 Pharmaceutical Preparations